Norway Dupixent Market Size & Outlook, 2025-2033

The dupixent market in Norway is expected to reach a projected revenue of US$ 74.6 million by 2033. A compound annual growth rate of 11% is expected of Norway dupixent market from 2025 to 2033.
Revenue, 2024 (US$M)
$28.8
Forecast, 2033 (US$M)
$74.6
CAGR, 2025 - 2033
11%
Report Coverage
Norway

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Norway dupixent market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Norway dupixent market highlights

  • The Norway dupixent market generated a revenue of USD 28.8 million in 2024 and is expected to reach USD 74.6 million by 2033.
  • The Norway market is expected to grow at a CAGR of 11% from 2025 to 2033.
  • In terms of segment, atopic dermatitis (ad) was the largest revenue generating type in 2024.
  • COPD is the most lucrative type segment registering the fastest growth during the forecast period.


Dupixent market data book summary

Market revenue in 2024USD 28.8 million
Market revenue in 2033USD 74.6 million
Growth rate11% (CAGR from 2025 to 2033)
Largest segmentAtopic dermatitis (ad)
Fastest growing segmentCOPD
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAtopic Dermatitis (AD), Asthma, CRSwNP, COPD, Other


Other key industry trends

  • In terms of revenue, Norway accounted for 0.2% of the global dupixent market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany dupixent market is projected to lead the regional market in terms of revenue in 2033.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 465.7 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Dupixent Market Companies

Name Profile # Employees HQ Website
Regeneron Pharmaceuticals Inc View profile 13450 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 https://www.regeneron.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

Norway dupixent market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupixent market will help companies and investors design strategic landscapes.


Atopic dermatitis (ad) was the largest segment with a revenue share of 78.47% in 2024. Horizon Databook has segmented the Norway dupixent market based on atopic dermatitis (ad), asthma, crswnp, copd, other covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Norway dupixent market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Norway dupixent market databook

  • Our clientele includes a mix of dupixent market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Norway dupixent market , including forecasts for subscribers. This country databook contains high-level insights into Norway dupixent market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Norway dupixent market size, by type, 2021-2033 (US$M)

Norway Dupixent Market Outlook Share, 2024 & 2033 (US$M)

Norway dupixent market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online